Michael Hoge - Accuray Incorporated Senior Operations

ARAY Stock  USD 2.03  0.04  1.93%   

Executive

Michael Hoge is Senior Operations of Accuray Incorporated
Age 57
Address 1240 Deming Way, Madison, WI, United States, 53717-1954
Phone608 824 2800
Webhttps://www.accuray.com

Accuray Incorporated Management Efficiency

Return On Capital Employed is likely to rise to 0 in 2024, whereas Return On Tangible Assets are likely to drop (0.04) in 2024. At this time, Accuray Incorporated's Other Current Assets are fairly stable compared to the past year. Fixed Asset Turnover is likely to rise to 8.99 in 2024, whereas Total Assets are likely to drop slightly above 394.4 M in 2024. Accuray Incorporated's management efficiency ratios could be used to measure how well Accuray Incorporated manages its routine affairs as well as how well it operates its assets and liabilities.
Accuray Incorporated currently holds 210.75 M in liabilities with Debt to Equity (D/E) ratio of 3.9, implying the company greatly relies on financing operations through barrowing. Accuray Incorporated has a current ratio of 1.65, which is within standard range for the sector. Note, when we think about Accuray Incorporated's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Marshall MDArtivion
67
Stephen JDSight Sciences
N/A
Jeffrey JonesCutera Inc
68
John ShumakerParagon 28
N/A
Matthew CPAApyx Medical
55
Stephanie WalshOrthofix Medical
N/A
Matthew BrinckmanParagon 28
N/A
Manohar RahejaSight Sciences
N/A
Dan YarbroughOrthofix Medical
N/A
Leah AkinNeuropace
N/A
Ivica MDAxogen Inc
N/A
Yuliya AslanParagon 28
N/A
Mark KarshnerOrthopediatrics Corp
N/A
Todd PuckettAxogen Inc
N/A
Harold TamayoAxogen Inc
N/A
Maria MartinezAxogen Inc
56
Tom HuangSight Sciences
N/A
Jeremy JDSight Sciences
54
Lucas VitaleOrthofix Medical
47
Anthony RecuperoSi Bone
65
Irene ThomasNeuropace
55
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California. Accuray operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1044 people. Accuray Incorporated (ARAY) is traded on NASDAQ Exchange in USA. It is located in 1240 Deming Way, Madison, WI, United States, 53717-1954 and employs 987 people. Accuray Incorporated is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Accuray Incorporated Leadership Team

Elected by the shareholders, the Accuray Incorporated's board of directors comprises two types of representatives: Accuray Incorporated inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Accuray. The board's role is to monitor Accuray Incorporated's management team and ensure that shareholders' interests are well served. Accuray Incorporated's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Accuray Incorporated's outside directors are responsible for providing unbiased perspectives on the board's policies.
Xavier Misouard, President Region
Melanie Gebauer, Vice Resources
GS Jha, Global Officer
Jesse Chew, Chief VP
Sandeep Chalke, Interim Officer
Nancy Hiller, President Region
Jim Dennison, Quality Regulatory
John Dunn, Chief President
Todd Brown, Senior Service
Joshua Levine, CEO and President and Director
JeanPhilippe Pignol, Chief VP
Franco Palomba, Chief VP
Patrick Spine, Sr Officer
Melanie Rivers, Chief VP
Ken Mobeck, VP Relations
Michael CPA, Principal officer
Juki Hozumi, President Region
Suzanne MBA, CEO President
MD MBA, Senior Officer
Mu Lee, Senior Development
Gina Corradetti, Chief VP
Beth Kaplan, Public Director
Michael Hoge, Senior Operations
Roger Cao, President REGION
Ali Pervaiz, Interim CFO
Jesse JD, Chief VP

Accuray Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Accuray Incorporated a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Accuray Stock Analysis

When running Accuray Incorporated's price analysis, check to measure Accuray Incorporated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accuray Incorporated is operating at the current time. Most of Accuray Incorporated's value examination focuses on studying past and present price action to predict the probability of Accuray Incorporated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accuray Incorporated's price. Additionally, you may evaluate how the addition of Accuray Incorporated to your portfolios can decrease your overall portfolio volatility.